Akebia Therapeutics (AKBA) Amortization - Intangibles: 2019-2024
Historic Amortization - Intangibles for Akebia Therapeutics (AKBA) over the last 6 years, with Dec 2024 value amounting to $9.0 million.
- Akebia Therapeutics' Amortization - Intangibles changed negligibly% to $9.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $36.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $36.0 million for FY2024, which is negligibly% changed negligibly from last year.
- Per Akebia Therapeutics' latest filing, its Amortization - Intangibles stood at $9.0 million for Q4 2024, which was down 0.01% from $9.0 million recorded in Q3 2024.
- Over the past 5 years, Akebia Therapeutics' Amortization - Intangibles peaked at $9.1 million during Q2 2020, and registered a low of $6.1 million during Q3 2020.
- Its 3-year average for Amortization - Intangibles is $9.0 million, with a median of $9.0 million in 2024.
- Per our database at Business Quant, Akebia Therapeutics' Amortization - Intangibles crashed by 32.91% in 2020 and then spiked by 47.58% in 2021.
- Over the past 5 years, Akebia Therapeutics' Amortization - Intangibles (Quarterly) stood at $8.3 million in 2020, then climbed by 8.42% to $9.0 million in 2021, then remained steady at $9.0 million in 2022, then remained steady at $9.0 million in 2023, then remained steady at $9.0 million in 2024.
- Its Amortization - Intangibles stands at $9.0 million for Q4 2024, versus $9.0 million for Q3 2024 and $9.0 million for Q2 2024.